Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Simulations Plus
SLP
Simulations Plus
AI Integration And Cloud Platforms Will Unlock In Silico Opportunities
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
15 Jun 25
Updated
23 Jul 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$31.00
58.4% undervalued
intrinsic discount
23 Jul
US$12.91
Loading
1Y
-65.4%
7D
-4.2%
Author's Valuation
US$31.0
58.4% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$31.0
58.4% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-63m
100m
2014
2017
2020
2023
2025
2026
2028
Revenue US$99.8m
Earnings US$25.7m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.28%
Healthtech revenue growth rate
4.16%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.78%
Calculation
US$25.75m
Earnings '28
x
29.85x
PE Ratio '28
=
US$768.49m
Market Cap '28
US$768.49m
Market Cap '28
/
20.31m
No. shares '28
=
US$37.84
Share Price '28
US$37.84
Share Price '28
Discounted to 2025 @ 7.42% p.a.
=
US$30.53
Fair Value '25